Abstract

The emerging human enteropathogen Clostridioides difficile is the main cause of diarrhea associated with antibiotherapy. Regulatory pathways underlying the adaptive responses remain understudied and the global view of C. difficile promoter structure is still missing. In the genome of C. difficile 630, 22 genes encoding sigma factors are present suggesting a complex pattern of transcription in this bacterium. We present here the first transcriptional map of the C. difficile genome resulting from the identification of transcriptional start sites (TSS), promoter motifs and operon structures. By 5′-end RNA-seq approach, we mapped more than 1000 TSS upstream of genes. In addition to these primary TSS, this analysis revealed complex structure of transcriptional units such as alternative and internal promoters, potential RNA processing events and 5′ untranslated regions. By following an in silico iterative strategy that used as an input previously published consensus sequences and transcriptomic analysis, we identified candidate promoters upstream of most of protein-coding and non-coding RNAs genes. This strategy also led to refine consensus sequences of promoters recognized by major sigma factors of C. difficile. Detailed analysis focuses on the transcription in the pathogenicity locus and regulatory genes, as well as regulons of transition phase and sporulation sigma factors as important components of C. difficile regulatory network governing toxin gene expression and spore formation. Among the still uncharacterized regulons of the major sigma factors of C. difficile, we defined the SigL regulon by combining transcriptome and in silico analyses. We showed that the SigL regulon is largely involved in amino-acid degradation, a metabolism crucial for C. difficile gut colonization. Finally, we combined our TSS mapping, in silico identification of promoters and RNA-seq data to improve gene annotation and to suggest operon organization in C. difficile. These data will considerably improve our knowledge of global regulatory circuits controlling gene expression in C. difficile and will serve as a useful rich resource for scientific community both for the detailed analysis of specific genes and systems biology studies.

Highlights

  • Clostridioides difficile is an emerging human enteropathogen causing nosocomial antibioticassociated diarrhea in adults (Carroll and Bartlett, 2011)

  • To increase the number of transcription start sites (TSSs) identified, the 5 -end RNA-seq analysis was realized with mixed RNA samples extracted from C. difficile 630 erm cells harvested during exponential growth phase (4 h), at the onset of stationary phase (10 h) and under nutrient starvation conditions

  • The lack of replicates could be a problem for genes expressed exclusively in one of tested conditions, based on our previous transcriptome analysis and gene-specific studies, we assume that the great part of genes is expressed at least in two or three samples

Read more

Summary

Introduction

Clostridioides difficile (formerly Clostridium difficile) is an emerging human enteropathogen causing nosocomial antibioticassociated diarrhea in adults (Carroll and Bartlett, 2011). Alarming incidence of C. difficile infections was further accentuated by the recent emergence of antibiotic resistance, of hypervirulent epidemic strains broadening the population at risk and severity of disease, high rate of recurrent infection as well as an overall aging of population in industrial countries (Rupnik et al, 2009; Banawas, 2018). This anaerobic, spore-forming, Gram-positive bacterium can be found in soil and aquatic environments as well as in intestinal tracts of humans and animals (Keessen et al, 2011). This information is largely missing and urgently needed for our understanding of the success of this pathogen and development of new diagnostic and therapeutic strategies

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.